\u201cThere is little, or no evidence base for many of the conditions for which it is being prescribed, such as anxiety, insomnia, or depression,\u201d McMullen said.<\/p>\n
In its submission to an Australian Government inquiry into the industry, the AMA called for \u201ccomprehensive reform\u201d of the way medical cannabis was bought and sold.<\/p>\n
Members working in emergency departments were calling for more resources to deal with growing numbers of patients with cases related to excessive intake of cannabis, including psychosis, the association said.<\/p>\n
\u201cAlarmingly, doctors are seeing medicinal cannabis use in people who have pre-existing psychotic conditions.\u201d<\/p>\n
The AMA warned that telehealth models \u2013 in which patients can be issued prescriptions online without an in-person doctor visit \u2013 were being \u201cexploited as commercial pathways for unapproved products\u201d.<\/p>\n
This year, newspaper the Age revealed that one doctor working for medical cannabis giant Montu had issued 72,000 prescriptions to 10,000 patients in just two years.<\/p>\n
In some instances, the newspaper reported, consultations with patients were scheduled to last no longer than 10 minutes.<\/p>\n
The global medical cannabis market is expected to grow to over US$65 billion by 2030, according to consulting firm Grand View Research.<\/p>\n
-Agence France-Presse<\/p>\n","protected":false},"excerpt":{"rendered":"\u201cThere is little, or no evidence base for many of the conditions for which it is being prescribed,…\n","protected":false},"author":2,"featured_media":497910,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4315],"tags":[12635,87189,106864,20726,114477,5205,163641,163642,105,806,49083,4554,4326,118045,3577,163643,7398,7395,1939,2443,8746,16,15,80480,115876,69978,53173,6095],"class_list":{"0":"post-497909","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-association","9":"tag-australian","10":"tag-australias","11":"tag-cannabis","12":"tag-countrys","13":"tag-doctors","14":"tag-excessive","15":"tag-excessively","16":"tag-health","17":"tag-industry","18":"tag-little","19":"tag-medical","20":"tag-medication","21":"tag-needs","22":"tag-of","23":"tag-oversight","24":"tag-pharmacists","25":"tag-prescribing","26":"tag-prescriptions","27":"tag-regulation","28":"tag-today","29":"tag-uk","30":"tag-united-kingdom","31":"tag-urgent","32":"tag-warn","33":"tag-warned","34":"tag-weed","35":"tag-with"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@uk\/115370711003808926","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/497909","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/comments?post=497909"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/497909\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media\/497910"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media?parent=497909"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/categories?post=497909"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/tags?post=497909"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}